Recombinant Technologies LLC, based in New Haven, is a pioneering biotechnology company focused on developing innovative treatments for Alzheimer's disease. Led by Dr. Pazhani Sundaram, the company's Amytrap technology offers a unique approach to safely treating Alzheimer's, with a current focus on developing small molecules for therapeutic use.
Through collaborations with Yale School of Medicine and clinical trials in India, Recombinant Technologies LLC is at the forefront of Alzheimer's disease drug development. Their groundbreaking research aims to provide a cure for Alzheimer's and improve the future of those affected by this debilitating condition.
Generated from their website's infomation